Article
Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
Oncotarget - 3 Nov 2015
Shen John Paul, Srivas Rohith, Gross Andrew, Li Jianfeng, Jaehnig Eric J, Sun Su Ming, Bojorquez-Gomez Ana, Licon Katherine, Sivaganesh Vignesh, Xu Jia L, Klepper Kristin, Yeerna Huwate, Pekin Daniel, Qiu Chu Ping, van Attikum Haico, Sobol Robert W, Ideker Trey
Abstract excerpt
Chemical inhibitors of the checkpoint kinases have shown promise in the treatment of cancer, yet their clinical utility may be limited by a lack of molecular biomarkers to identify specific patients most likely to respond to therapy. To this end, we screened 112 known tumor suppressor genes for synthetic lethal interactions with inhibitors of the CHEK1 and CHEK2 checkpoint kinases. We identified eight...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
